English version - This handbook sets out a the new paradigm for pharmacy practice. Its aim is to guide pharmacy educators in pharmacy practice, to educate pharmacy students and to guide pharmacists in practice to update their skills. The handbook, which brings together practical tools and knowledge,... has been written in response to a need to define, develop and generate global understanding of pharmaceutical care at all levels.
more
A summary of the national drug situation
15 July 2021. This report describes the demographics, clinical presentation, clinical outcomes, and risk factors among people living with HIV (PLHIV) who have been hospitalized for suspected or confirmed COVID-19.
The specific objectives of the analysis were to:
describe the clinical char...acteristics and outcomes of PLHIV hospitalized for COVID-19
assess whether PLHIV hospitalized with COVID-19 were at increased risk of presenting with severe or critical illness at admission and were at increased risk of in-hospital death compared to individuals not infected with HIV
assess risk factors associated with severe or critical illness at hospital admission and of in-hospital death among PLHIV hospitalized for COVID-19.
more
BMC Public Health (2016) 16:766
DOI 10.1186/s12889-016-3455-5
Int J Environ Res Public Health. 2018 Jun; 15(6): 1279.
Published online 2018 Jun 16. doi: 10.3390/ijerph15061279
DHS Further Analysis Reports No. 103
BMC Public Health (2019) 19:1608
https://doi.org/10.1186/s12889-019-7853-3
Die Broschüre erklärt Themen wie Grüßen, Allah / Gott / JHWH, Bildung, Arbeit, Geschichte, Grundgesetz, Gleichberechtigung und Diskriminierung, Umwelt u.a. und unterscheidet sich von bisherigen Veröffentlichungen und Angeboten dadurch, dass die Inhalte islamisch begründet werden. Damit ist die... Handreichung für muslimische Adressaten von essentiell anderer Qualität und kann entscheidend höhere Akzeptanz erreichen!
Die Broschüre liegt vor in Arabisch, Englisch, Deutsch (weitere Sprachen in Vorbereitung)
more
WHO published guidance for clinicians and health care decision-makers on the use of corticosteroids in patients with COVID-19.
We recommend systemic corticosteroids for the treatment of patients with severe and critical COVID-19. We suggest not to use corticosteroids in the treatment of patients ...with non-severe COVID-19 as the treatment brought no benefits, and could even prove harmful. Treatment should be under supervision of a clinician.
Corticosteroids are listed in the WHO model list of essential medicines, readily available globally at a low cost. WHO encourages countries to maintain sufficient stocks of corticosteroids to treat COVID-19 and the other disease for which they are effective, while not maintaining excessive stocks which could deny other countries access.
more